Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Carcinogenesis Retrieve available abstracts of 30 articles: HTML format

Single Articles

August 2022
1. LU F, Zhou J, Chen Q, Zhu J, et al
   PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
   Carcinogenesis. 2022;43:624-634.
   PubMed     Abstract available
   
   
   
2. SATOH H, Arai Y, Furukawa E, Moriguchi T, et al
   Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels.
   Carcinogenesis. 2022;43:613-623.
   PubMed     Abstract available
   
   
   
3. BIAN T, Ding H, Wang Y, Hu Q, et al
   Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.
   Carcinogenesis. 2022;43:659-670.
   PubMed     Abstract available
   
   
   June 2022
4. KASSIE F, Bagherpoor AJ, Kovacs K, Seelig D, et al
   Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation.
   Carcinogenesis. 2022;43:547-556.
   PubMed     Abstract available
   
   
   
5. FENG J, Ouyang H, Wang J, Pan D, et al
   MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
   Carcinogenesis. 2022 Jun 21. pii: 6612224. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. ZHAO A, Li F, Wei C, Zhou Z, et al
   TNFalpha antagonist in combination with PD-1 blocker to prevent or retard malignant transformation of B[a]P-induced chronic lung inflammation.
   Carcinogenesis. 2022;43:445-456.
   PubMed     Abstract available
   
   
   May 2022
7. YOON HS, Shu XO, Cai H, Zheng W, et al
   Associations of Lung Cancer Risk with Biomarkers of Helicobacter pylori Infection.
   Carcinogenesis. 2022 May 24. pii: 6590911. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2022
8. HU Q, Upadhyaya P, Hecht SS, Aly FZ, et al
   Characterization of adductomic totality of NNK, (R)-NNAL and (S)-NNAL in A/J mice, and their correlations with distinct lung carcinogenicity.
   Carcinogenesis. 2022;43:170-181.
   PubMed     Abstract available
   
   
   February 2022
9. MENG Z, Zhang R, Wu X, Zhang M, et al
   Prognostic value of Mortalin correlates with roles in epithelial-mesenchymal transition and angiogenesis in lung adenocarcinoma.
   Carcinogenesis. 2022;43:40-51.
   PubMed     Abstract available
   
   
   January 2022
10. ZHANG Q, Jia Y, Pan P, Zhang X, et al
    alpha5-nAChR associated with Ly6E modulates cell migration via TGF-beta1/Smad signaling in non-small cell lung cancer.
    Carcinogenesis. 2022 Jan 5. pii: 6498141. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
11. DONNELLY LL, Hogan TC, Lenahan SM, Nandagopal G, et al
    Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
    Carcinogenesis. 2021;42:1428-1438.
    PubMed     Abstract available
    
    
    
12. XU R, Yan Y, Zheng X, Zhang H, et al
    Aspirin Suppresses Breast Cancer Metastasis to Lung by Targeting Anoikis Resistance.
    Carcinogenesis. 2021 Dec 27. pii: 6484923. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. YANG L, Wu D, Chen J, Chen J, et al
    Corrigendum to: A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Carcinogenesis. 2021 Dec 23. pii: 6481929. doi: 10.1093.
    PubMed    
    
    
    
14. LI H, Zhao S, Chen X, Feng G, et al
    MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3.
    Carcinogenesis. 2021 Dec 9. pii: 6458453. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. HUDLIKAR RR, Sargsyan D, Cheng D, Kuo HD, et al
    Tobacco carcinogen 4-[Methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK) drives metabolic rewiring and epigenetic reprograming in A/J mice lung cancer model and prevention with Diallyl Sulphide (DAS).
    Carcinogenesis. 2021 Dec 9. pii: 6458449. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
16. WANG M, Li S, Guo W, Wang L, et al
    CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity.
    Carcinogenesis. 2021 Oct 27. pii: 6412599. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
17. ANG L, Ghosh P, Seow WJ
    Association between previous lung diseases and lung cancer risk: a systematic review and meta-analysis.
    Carcinogenesis. 2021 Sep 6. pii: 6364950. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
18. HE T, Ling F
    CALCR knockdown inhibits the development and progression of non-small-cell lung cancer.
    Carcinogenesis. 2021 Aug 21. pii: 6356050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. TAO K, Liu J, Liang J, Xu X, et al
    Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.
    Carcinogenesis. 2021;42:1056-1067.
    PubMed     Abstract available
    
    
    
20. WANG Q, Ru M, Zhang Y, Kurbanova T, et al
    Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial.
    Carcinogenesis. 2021 Aug 9. pii: 6346800. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
21. WANG Y, Ji M, Zhu M, Fan J, et al
    Genome-wide gene-smoking interaction study identified novel susceptibility loci for non-small cell lung cancer in Chinese populations.
    Carcinogenesis. 2021 Jul 23. pii: 6326566. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. CHEN W, Saxton B, Tessema M, Belinsky SA, et al
    Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein.
    Carcinogenesis. 2021 Jul 16. pii: 6322888. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. LI Z, Pan C, Wang Z, Deng X, et al
    LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Carcinogenesis. 2021;42:931-939.
    PubMed     Abstract available
    
    
    
24. CUI D, Zhu Y, Yan D, Lee NPY, et al
    Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma.
    Carcinogenesis. 2021;42:995-1007.
    PubMed     Abstract available
    
    
    June 2021
25. XIAN J, Zeng Y, Chen S, Lu L, et al
    Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
    Carcinogenesis. 2021;42:831-841.
    PubMed     Abstract available
    
    
    
26. CHEN H, Lu C, Lin C, Li L, et al
    VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy.
    Carcinogenesis. 2021;42:880-890.
    PubMed     Abstract available
    
    
    April 2021
27. JIANG T, Wu H, Lin M, Yin J, et al
    B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway.
    Carcinogenesis. 2021;42:621-630.
    PubMed     Abstract available
    
    
    
28. GUI HX, Peng J, Yang ZP, Chen LY, et al
    HDAC1-Smad3-mSin3A complex is required for Smad3-induced transcriptional inhibition of hepatocyte growth factor receptor in human lung cancers.
    Carcinogenesis. 2021;42:587-600.
    PubMed     Abstract available
    
    
    February 2021
29. HAMADA K, Tian Y, Fujimoto M, Takahashi Y, et al
    DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
    Carcinogenesis. 2021;42:169-179.
    PubMed     Abstract available
    
    
    
30. LI P, Zhang X, Murphy AJ, Costa M, et al
    Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
    Carcinogenesis. 2021;42:136-147.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: